These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 978769)

  • 1. Comparison of the potentiation of specific tumor immunity in mice by Corynebacterium parvum or BCG.
    Scott MT; Bomford R
    J Natl Cancer Inst; 1976 Sep; 57(3):555-9. PubMed ID: 978769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental cancer immunotherapy: comparison of tumor rejection if F344 rats given live Mycobacterium bovis (Strain BCG) and killed Corynebacterium parvum.
    Likhite VV
    J Natl Cancer Inst; 1976 May; 56(5):985-9. PubMed ID: 994209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor activity of purified cell walls from Corynebacterium parvum.
    Riveros-Moreno V; Bomford R; Scott MT
    J Natl Cancer Inst; 1978 Mar; 60(3):653-8. PubMed ID: 625069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumour effects of Corynebacterium parvum in mice.
    Castro JE
    Eur J Cancer (1965); 1974 Feb; 10(2):121-7. PubMed ID: 4435007
    [No Abstract]   [Full Text] [Related]  

  • 5. Relationship between intradermal tumor suppression and tumor immunity.
    Bartlett GL; Kreider JW; Purnell DM
    J Natl Cancer Inst; 1976 Dec; 57(6):1297-303. PubMed ID: 794505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunity to transplantable carcinogen-induced fibrosarcomas in B2/B2 chickens. I. Use of bacterial adjuvants in induction of immunity demonstrable in Winn tests.
    Palladino MA; Thorbecke GJ
    Cell Immunol; 1978 Jul; 38(2):336-49. PubMed ID: 354799
    [No Abstract]   [Full Text] [Related]  

  • 7. Abrogation of antitumor effects of Corynebacterium parvum and BCG by antimacrophage agents: brief communication.
    Keller R
    J Natl Cancer Inst; 1977 Dec; 59(6):1751-3. PubMed ID: 200763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corynebacterium parvum and cyclophosphamide as combination treatment for a murine mammary adenocarcinoma.
    Purnell DM; Bartlett GL; Kreider JW; Biro TG
    Cancer Res; 1977 Apr; 37(4):1137-40. PubMed ID: 844041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Corynebacterium parvum treatment of mice with sarcoma growing in normal or irradiated tissue.
    Suit HD; Sedlacek R; Echteler S
    Cancer Res; 1977 Nov; 37(11):4233-4. PubMed ID: 908052
    [No Abstract]   [Full Text] [Related]  

  • 10. B7-1/CD80-transduced tumor cells elicit better systemic immunity than wild-type tumor cells admixed with Corynebacterium parvum.
    Chen L; McGowan P; Ashe S; Johnston JV; Hellström I; Hellström KE
    Cancer Res; 1994 Oct; 54(20):5420-3. PubMed ID: 7522958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of BCG and Corynebacterium Parvum on allograft survival after rabbit antimouse lymphocyte serum and donor bone marrow.
    Clark AW; Monaco AP
    Surg Forum; 1973; 24():340-3. PubMed ID: 4618660
    [No Abstract]   [Full Text] [Related]  

  • 12. Stimulation of the non-specific resistance by Corynebacterium parvum and Bacillus calmette Guérin.
    Ruitenberg EJ; Steerenberg PA
    Tijdschr Diergeneeskd; 1976 Jul; 101(14):775-8. PubMed ID: 821172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lectin potentiation of BCG-contact-mediated antitumor action.
    Poduval TB; Seshadri M; Sundaram K
    J Natl Cancer Inst; 1980 Nov; 65(5):909-12. PubMed ID: 6933260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the in-vitro antitumor activity of peritoneal cells from mice injected with Corynebacterium parvum and Corynebacterium liquefaciens.
    Toge T; Hattori T
    Hiroshima J Med Sci; 1979 Jun; 28(2):95-101. PubMed ID: 478988
    [No Abstract]   [Full Text] [Related]  

  • 15. Potentiation of the tumor-specific immune response by Corynebacterium parvum.
    Scott MT
    J Natl Cancer Inst; 1975 Jul; 55(1):65-72. PubMed ID: 808637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor activity of killed Corynebacterium parvum suspensions in a murine mammary adenocarcinoma CaD2) system.
    Purnell DM; Otterstrom JR; Bartlett GL; Kreider JW
    J Natl Cancer Inst; 1976 Jun; 56(6):1171-5. PubMed ID: 994219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of anti-thymocyte serum, anti-macrophage serum, and latex particles on the therapeutic efficacy of BCG or Corynebacterium liquefaciens (Propionibacterium acnes C7) in syngeneic mice.
    Tanaka T; Nakagawa H; Kato A; Yoshimura M; Fujita H; Kimura K
    Gan; 1977 Feb; 68(1):45-52. PubMed ID: 324858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor growth inhibition and potentiation of immunotherapy by indomethacin in mice.
    Lynch NR; Salomon JC
    J Natl Cancer Inst; 1979 Jan; 62(1):117-21. PubMed ID: 281566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification of the antitumor action of Corynebacterium parvum by stress.
    Turney TH; Harmsen AG; Jarpe MA
    Physiol Behav; 1986; 37(4):555-8. PubMed ID: 3092254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunopotentiation with BCG: dimensions of a specific antitumor response.
    Hawrylko E
    J Natl Cancer Inst; 1975 May; 54(5):1189-97. PubMed ID: 805254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.